Arrhythmias & electrophysiology

Improving guideline-based anticoagulation in atrial fibrillation: A systematic literature review of prospective trials

Heart RhythmPublished Systematic review of prospective randomised trials

Authors' conclusion

Interventions aimed at improving anticoagulation prescribing patterns in AF can be effective, although there is heterogeneity in outcomes across intervention type. The most effective interventions appeared to target patient education, provider education, and electronic risk assessment or decision support.

Study context

Population
Patients with atrial fibrillation (AF) with an indication for anticoagulation20 trials
Comparison
Population-based interventions to decrease the AF anticoagulation gap
Outcome
Efficacy in decreasing the AF anticoagulation gap (anticoagulation prescribing)
Methodological detailsindividually randomised and cluster randomised trials, prospectively registered, Search of PubMed, Google Scholar, Web of Science and Medline; 1474 studies reviewed
  • Individually randomised and cluster randomised trials
  • Prospectively registered
  • Search of PubMed, Google Scholar, Web of Science and Medline; 1474 studies reviewed

Pooled result

As reported in the abstract

Trials effective in decreasing the AF anticoagulation gap
OutcomePatient educationProvider educationElectronic risk assessment or decision support
Absolute increase in appropriate anticoagulation prescribing8.3%4.9%2.0%
Trials effective in decreasing the AF anticoagulation gap
45%

Further pooled results

Trials improving anticoagulation prescribing, by setting

Ambulatory trials
6 of 15
Inpatient trials
2 of 4
Inpatient and outpatient trial
1

Original publication

Improving guideline-based anticoagulation in atrial fibrillation: A systematic literature review of prospective trials. Heart Rhythm. Published 17 September 2022. doi:10.1016/j.hrthm.2022.09.011

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.